Skip to content

Evaluation of High-Frequency Chest Wall Oscillation

Evaluation of High-Frequency Chest Wall Oscillation Using the Vest Airway Clearance System Compared to Conventional Chest Physical Therapy at Barnes-Jewish Hospital

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00717873
Enrollment
105
Registered
2008-07-18
Start date
2008-06-30
Completion date
2010-12-31
Last updated
2017-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Secretion Clearance

Keywords

Mucus Clearance, Secretion Clearance, HFCWO

Brief summary

To compare the outcomes of patients treated with the Vest and conventional chest physiotherapy to determine if the Vest provides equivalent therapy

Interventions

DEVICEAirway clearance Device

Provided by the Vest Airway clearance system

Sponsors

Hill-Rom
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute or chronic disease requiring secretion mobilization as per hospital protocol

Exclusion criteria

* Absolute contraindications for positional changes * Absolute contraindications for chest percussion * Women visibly pregnant * Previous enrollment in study * Previous CPT or Vest treatment

Design outcomes

Primary

MeasureTime frameDescription
Hospital Length of StayAdmission to Dischargean average of 10 days

Countries

United States

Participant flow

Participants by arm

ArmCount
HFCWO Arm
Airway clearance provided by the Vest Airway Clearance System
46
CPT Arm
Airway clearance provided by manual CPT
59
Total105

Baseline characteristics

CharacteristicHFCWO ArmCPT ArmTotal
Age, Continuous42 years
STANDARD_DEVIATION 18
45 years
STANDARD_DEVIATION 18
44 years
STANDARD_DEVIATION 18
Sex: Female, Male
Female
17 Participants33 Participants50 Participants
Sex: Female, Male
Male
29 Participants26 Participants55 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 460 / 59
serious
Total, serious adverse events
0 / 460 / 59

Outcome results

Primary

Hospital Length of Stay

an average of 10 days

Time frame: Admission to Discharge

ArmMeasureValue (MEAN)Dispersion
HFCWO ArmHospital Length of Stay2.95 daysStandard Deviation 1.01
CPT ArmHospital Length of Stay5.45 daysStandard Deviation 1.84

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026